Francis M Dijkstra (Francis Dijkstra)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Endothelial Cells

Major Depressive Disorder

Top Venues

Translational psychiatry

British journal of clinical pharmacology

Journal of psychopharmacology (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Francis M Dijkstra, Rob G J A Zuiker, Jules A A C Heuberger, Kawita M S Kanhai, Marieke De Kam, Thierry Duvauchelle, Jeanne-Marie Lecomte, Olivier Labeeuw, Laurent Landais, Xavier Ligneau, Philippe Robert, Marc Capet, Jean-Charles Schwartz, Joop M A van Gerven
Administration of oxathridine, a first-in-class histamine-3 receptor partial agonist in healthy male volunteers: central nervous system depression and pseudo-hallucinations. British journal of clinical pharmacology (2023)
Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Guilherme S Ferreira, Francis M Dijkstra, Désirée H Veening-Griffioen, Wouter P C Boon, Huub Schellekens, Ellen H M Moors, Peter J K van Meer, Frederik E Stuurman, Joop M A van Gerven
Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational psychiatry 13 (1) (2023)
Francis M Dijkstra, Aurora Jae van de Loo, Smedra Abdulahad, Else R Bosma, Mitch Hartog, Hendrikje Huls, Dianne C Kuijper, Esther de Vries, Bhavna Solanki, Jaskaran Singh, Leah Aluisio, Peter Zannikos, Frederik E Stuurman, Gabriël E Jacobs, Joris C Verster
The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder. Journal of psychopharmacology (Oxford, England) 36 (5) (2022)
Francis M Dijkstra, Patricio O'Donnell, Erica Klaassen, Derek L Buhl, Mahnaz Asgharnejad, Laura Rosen, Rob G J A Zuiker, Joop van Gerven, Gabriël Jacobs
Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers. Translational psychiatry 12 (1) (2022)
Francis M Dijkstra, Rob G J A Zuiker, Pieter S Siebenga, Richard A Leigh-Pemberton, Lei Sun, Joan D Manthis, Marieke L de Kam, Richard Lin, Lisa L von Moltke, David Rezendes, Joop M A van Gerven
Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers. British journal of clinical pharmacology 88 (6) (2022)